Annual CFF
$416.48 M
+$435.45 M+2295.34%
01 December 2023
Summary:
BeiGene annual cash flow from financing activities is currently $416.48 million, with the most recent change of +$435.45 million (+2295.34%) on 01 December 2023. During the last 3 years, it has fallen by -$3.22 billion (-88.55%).ONC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$12.66 M
-$10.36 M-44.99%
01 September 2024
Summary:
BeiGene quarterly cash flow from financing activities is currently $12.66 million, with the most recent change of -$10.36 million (-44.99%) on 01 September 2024. Over the past year, it has dropped by -$334.39 million (-96.35%).ONC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$545.02 M
+$89.44 M+19.63%
01 September 2024
Summary:
BeiGene TTM cash flow from financing activities is currently $545.02 million, with the most recent change of +$89.44 million (+19.63%) on 01 September 2024. Over the past year, it has increased by +$128.54 million (+30.86%).ONC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONC Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -96.3% | +30.9% |
| 3 y3 years | -88.5% | -99.6% | -85.0% |
| 5 y5 years | +386.1% | +476.1% | +536.1% |
ONC Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -92.0% | -99.6% | -89.5% |
BeiGene Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.66 M(-45.0%) | $545.02 M(+19.6%) |
| June 2024 | - | $23.02 M(-85.8%) | $455.58 M(-23.9%) |
| Mar 2024 | - | $162.29 M(-53.2%) | $598.64 M(+43.7%) |
| Dec 2023 | $416.48 M(-2295.3%) | $347.05 M(-552.0%) | $416.48 M(-1117.4%) |
| Sept 2023 | - | -$76.78 M(-146.2%) | -$40.94 M(-126.2%) |
| June 2023 | - | $166.08 M(-935.9%) | $156.09 M(-666.1%) |
| Mar 2023 | - | -$19.87 M(-82.0%) | -$27.57 M(+45.3%) |
| Dec 2022 | -$18.97 M(-100.5%) | -$110.37 M(-191.8%) | -$18.97 M(-100.5%) |
| Sept 2022 | - | $120.24 M(-784.0%) | $3.48 B(+0.3%) |
| June 2022 | - | -$17.58 M(+56.0%) | $3.47 B(-1.5%) |
| Mar 2022 | - | -$11.27 M(-100.3%) | $3.52 B(-3.3%) |
| Dec 2021 | $3.64 B(-30.1%) | $3.38 B(+2999.3%) | $3.64 B(+529.3%) |
| Sept 2021 | - | $109.21 M(+206.5%) | $577.91 M(-76.5%) |
| June 2021 | - | $35.63 M(-66.8%) | $2.46 B(-1.8%) |
| Mar 2021 | - | $107.42 M(-67.0%) | $2.51 B(-51.8%) |
| Dec 2020 | $5.20 B(+5972.4%) | $325.66 M(-83.7%) | $5.20 B(+6.6%) |
| Sept 2020 | - | $1.99 B(+2361.9%) | $4.88 B(+67.6%) |
| June 2020 | - | $80.99 M(-97.1%) | $2.91 B(+2.3%) |
| Mar 2020 | - | $2.80 B(>+9900.0%) | $2.84 B(+3220.4%) |
| Dec 2019 | $85.68 M | $2.20 M(-91.3%) | $85.68 M(-7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $25.14 M(+63.4%) | $92.28 M(-90.2%) |
| June 2019 | - | $15.38 M(-64.2%) | $938.40 M(-3.2%) |
| Mar 2019 | - | $42.96 M(+388.1%) | $969.60 M(-42.6%) |
| Dec 2018 | $1.69 B(+244.8%) | $8.80 M(-99.0%) | $1.69 B(+0.3%) |
| Sept 2018 | - | $871.25 M(+1770.3%) | $1.68 B(+46.1%) |
| June 2018 | - | $46.58 M(-93.9%) | $1.15 B(-7.9%) |
| Mar 2018 | - | $763.90 M(>+9900.0%) | $1.25 B(+155.3%) |
| Dec 2017 | $490.36 M(+28.7%) | $3.05 M(-99.1%) | $490.36 M(-28.5%) |
| Sept 2017 | - | $339.71 M(+134.2%) | $686.00 M(+93.8%) |
| June 2017 | - | $145.07 M(+5627.1%) | $353.93 M(+65.9%) |
| Mar 2017 | - | $2.53 M(-98.7%) | $213.39 M(-44.0%) |
| Dec 2016 | $380.90 M(+269.1%) | $198.69 M(+2500.7%) | $380.90 M(+109.2%) |
| Sept 2016 | - | $7.64 M(+69.0%) | $182.09 M(+0.7%) |
| June 2016 | - | $4.52 M(-97.3%) | $180.82 M(-33.8%) |
| Mar 2016 | - | $170.05 M(<-9900.0%) | $273.25 M(+164.8%) |
| Dec 2015 | $103.20 M(+97.8%) | -$119.00 K(-101.9%) | $103.20 M(-0.1%) |
| Sept 2015 | - | $6.37 M(-93.4%) | $103.32 M(+6.6%) |
| June 2015 | - | $96.95 M(>+9900.0%) | $96.95 M(>+9900.0%) |
| Mar 2015 | - | $0.00 | $0.00 |
| Dec 2014 | $52.16 M(<-9900.0%) | - | - |
| Dec 2013 | -$482.00 K | - | - |
FAQ
- What is BeiGene annual cash flow from financing activities?
- What is the all time high annual CFF for BeiGene?
- What is BeiGene quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for BeiGene?
- What is BeiGene quarterly CFF year-on-year change?
- What is BeiGene TTM cash flow from financing activities?
- What is the all time high TTM CFF for BeiGene?
- What is BeiGene TTM CFF year-on-year change?
What is BeiGene annual cash flow from financing activities?
The current annual CFF of ONC is $416.48 M
What is the all time high annual CFF for BeiGene?
BeiGene all-time high annual cash flow from financing activities is $5.20 B
What is BeiGene quarterly cash flow from financing activities?
The current quarterly CFF of ONC is $12.66 M
What is the all time high quarterly CFF for BeiGene?
BeiGene all-time high quarterly cash flow from financing activities is $3.38 B
What is BeiGene quarterly CFF year-on-year change?
Over the past year, ONC quarterly cash flow from financing activities has changed by -$334.39 M (-96.35%)
What is BeiGene TTM cash flow from financing activities?
The current TTM CFF of ONC is $545.02 M
What is the all time high TTM CFF for BeiGene?
BeiGene all-time high TTM cash flow from financing activities is $5.20 B
What is BeiGene TTM CFF year-on-year change?
Over the past year, ONC TTM cash flow from financing activities has changed by +$128.54 M (+30.86%)